陳俊興(Chen, Chun-Hsin) 教授

Email
chchen@tmu.edu.tw
現   職
精神學科 教授

學經歷

學 歷

畢業學校與學位[修業時間]
國立台灣大學流行病學研究所 碩士
2000/09~2003/06
國立臺灣大學醫學系 學士
1986/09~1993/06

本校學術經歷

任職單位與職稱[起迄時間]
精神學科教授
2018/02/01~
精神學科副教授
2012/02/01~2018/01/31
精神學科助理教授
2011/08/01~2012/01/31
精神學科助理教授
2009/02/01~2010/07/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
無資料!

其它經歷

任職單位與職稱[起迄時間]
臺北市立萬芳醫院精神科主治醫師
臺北市立忠孝醫院精神科主治醫師
1999/03~2003/08
臺北市立療養院住院醫師
1995/07~1999/03

專長與研究領域

學門領域
一般精神醫學
成癮醫學
精神藥理學
精神流行病學
學術專長
精神分裂症
Schizophrenia
憂鬱症
Depressive disorders
成癮疾患
Substance use disorders
生物精神醫學
生物精神醫學
精神藥理學
精神藥理學
成癮科學
成癮科學

論文著作

清冊下載


1. 2023 Huang, M. C.,Chen, C. H.,Liu, T. H.,Chung, A. N.,Liu, Y. L.,Quednow, B. B. & Bavato, F.. Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology . Psychiatric Research .2023

2. 2022 Chen, P. Y., ., ., ., ,Chiu, C. C.,,Hsieh, T. H,Liu, Y. R,Chen, C. H,Huang, C. Y., Lu, M. L. & Huang, M. C. The relationship of antipsychotic treatment with reduced brown adipose tissue activity in patients with schizophrenia . Psychoneuroendocrinology .2022

3. 2022 Su, M. H.,Liao, S. C,Chen, H. C.,Lu, M. L,Chen, W. Y.,Hsiao, P. C., Chen, C. H., Huang, M. C. & Kuo, P. H.. The association of personality polygenic risk score, psychosocial protective factors and suicide attempt in mood disorder . Journal of Psychiatric Research .2022

4. 2022 Chen, C. H.,Huang, M. C,Chiu, Y. H,Chen, I. M,Chen, C-H.,, Lu, M. L., Wang, T. Y., Chen, H. C. & Kuo, P. H. Stress Susceptibility Moderates the Relationship Between Eveningness Preference and Poor Sleep Quality in Non-Acute Mood Disorder Patients and Healthy Controls . Nature and Science of Sleep .2022

5. 2022 Chen, P. Y..,Chang, C. K.,Chen, C. H.,Fang, S. C.,Mondelli, V,Chiu, C. C., Lu, M. L., Hwang, L. L. & Huang, M. C.. Orexin-a elevation in antipsychotic-treated compared to drug-free patients with schizophrenia: A medication effect independent of metabolic syndrome . Journal of the Formosan Medical Association .2022

6. 2022 Chun-I Liu,Kah Kheng Goh,Chun-Hsin Chen. Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review . Front Psychiatry .2022

7. 2022 Chen, H. M.,Chung, Y. C. E.,Chen, H. C.,Liu, Y. W.,Chen, I. M., Lu, M. L., Hsiao, F. S. H., Chen, C. H., Huang, M. C., Shih, W. L. & Kuo, P. H.. Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder . Scientific Reports .2022

8. 2022 Goh, K. K.,Chen, C. H., Wu, T. H. , Chiu, Y. H. & Lu, M. L., . Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials . Frontiers in Pharmacology .2022

9. 2022 Goh, K. K.,,Chen, C. Y. A.,Wu, T. H.,Chen, C. H., Lu, M. L.. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction . International journal of molecular sciences .2022

10. 2021 Goh, K. K.,Chen, C. Y. A.,Chen, C. H.,Lu, M. L.. Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials . Journal of Psychopharmacology .2021

11. 2021 Goh, K. K.,, Wu, T. H.,Chen, C. H. ,Lu, M. L.. Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials . Journal of Psychopharmacology .2021

12. 2021 Wu, T. H.,,Lin, C. H..,Goh, K. K.,Chen, C. Y. A.,Chen, C. H.,Lane, H. Y. & Lu, M. L. The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment . Frontiers in Pharmacology .2021

13. 2021 Hung, Y. C., Chen, H. C., Kuo, P. H.,Lu, M. L.,Huang, M. C., Chen, C. H., Wang, S., Mao, W. C., Wu, C. S. & Wu, T. H.. Visualizing patterns of medication switching among major depressive patients with various stability and difficulty to treatments . Neuropsychiatric Disease and Treatment .2021

14. 2021 Giannakopoulou, O.,Lin, K.,Meng, X.,Su, M. H.,Kuo, P. H.,Peterson, R. E., Awasthi, S., Moscati, A., Coleman, J. R. I., Bass, N., Millwood, I. Y., Chen, Y., Chen, Z., Chen, H. C., Lu, M. L., Huang, M. C., Chen, C. H., Stahl, E. A., Loos, R. J. F., Mullins, N. The Genetic Architecture of Depression in Individuals of East Asian Ancestry: A Genome-Wide Association Study . JAMA Psychiatry .2021

15. 2021 Sze-Yu Chen,Chun-Hao Chen,Chen Lo,Mong-Liang Lu,Cheng-Dien Hsu,Yi-Hang Chiu, Chun-Hsin Chen, Shih-Ku Lin, Ming-Chyi Huang, Hsi-Chung Chen, Po-Hsiu Kuo. Differential Co-Occurring Patterns Between Depressive Symptomatology and Sleep-Wake-Related Disturbances in Mood Disorders . Nature and Science of Sleep .2021 ;(13):503-514

16. 2021 Chen HM,Kuo PH,Hsu CY,Chiu YH,Liu YW,Lu ML, Chen CH. Psychophysiological Effects of Lactobacillus plantarum PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial . Nutrients .2021

17. 2021 Chen CH,Chen PY,Chen CY,Chiu CC,Lu ML,Huang MC, Lin YK, Chen YH. Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia . International journal of environmental research and public health .2021

18. 2021 Chen SY,Chen CH,Lo C,Lu ML,Hsu CD,Chiu YH, Chen CH, Lin SK, Huang MC, Chen HC, Kuo PH. Differential Co-Occurring Patterns Between Depressive Symptomatology and Sleep-Wake-Related Disturbances in Mood Disorders . Nature and Science of Sleep .2021

19. 2021 Goh KK ,Chen CH,Lane HY. Oxytocin in schizophrenia: Pathophysiology and implications for future treatment . International journal of molecular sciences .2021

20. 2021 Chen CY,Goh KK,Chen CH,Lu ML. The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia . Frontiers in Psychiatry .2021

21. 2020 Cheng YC,Liu SI,Chen CH,Liu HC,Lu ML,Chang CJ, Chiu WC, Sun W, Yao LS, Chiu CC, Robert S. Comparison of cognitive function between early- and late-onset late-life depression in remission . Psychiatry Research .2020

22. 2020 Yi-Hang Chiu,Chia-Yueh Hsu,Mong-Liang Lu,Chun-Hsin Chen. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia . Current Pharma Design .2020 ;(26):218-227

23. 2020 Chiu YH,Hsu CY,Lu ML,Chen CH. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia . Current Pharma Design .2020 ;(26):218-227

24. 2020 Huang MC, Chen CH, Chen LY, Chang HM, ,Chen CH,Chen LY,Chang HM,Chen CK,Lin SK, Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation . Psychopharmacology (Berl). .2020

25. 2019 Lian-Yu Chen,Chih-Ken Chen ,Chun-Hsin Chen,Hu-Ming Chang,Ming-Chyi Huang,Ke Xu. Association of Craving and Depressive Symptoms in Ketamine-Dependent Patients Undergoing Withdrawal Treatment . The American Journal on Addictions .2019 ;(29):43-50

26. 2019 Chen PY,Chen CH,Chang CK,Kao CF,Lu ML,Lin SK, Huang MC, Hwang LL, Mondelli V. Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics . Int J Neuropsychopharmacol .2019 ;(22):28-36

27. 2019 Exploration of microbiota targets for major depressive disorder and mood related traits . J Psychiatric Research .2019 ;(111):74-82

28. 2019 The Association Between the Sedative Loads and Clinical Severity Indicators in the First-Onset Major Depressive Disorder . Frontier Psychiatry .2019 ;(10):129

29. 2019 Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life. . Psychiatry Research .2019 ;(276):1-5

30. 2019 Chang JS,Chiu YH,Pan CC,Chen CH. Probiotics Lactobacillun Plantarum PS128 intervention in two patients with major depressive disorder . Taiwanese J Psychiatry .2019

31. 2019 Wu TH,Chiu CC,Chen PY,Huang MC,Chen CH,Shen WW, Lu ML. Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life . Psychiatry Research .2019

32. 2019 Goh KK,Chen CH,Chiu YH,Lu ML. Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety . Journal of Psychopharmacology .2019

33. 2019 Huang MC,Chen CH,Chen LY,Chang HM,Chen CK,Lin SK, Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation . Psychopharmacology .2019

34. 2019 Chen PH,Liu HC,Lu ML,Chen CH,Chang CJ,Chiu WC, Sun IW, Liu SI, Tsai SY, Chiu CC, Stewart R. Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder . Int J Geriatr Psychiatry .2019

35. 2019 Wu TH,Chiu CC,Goh KK,Chen PY,Huang MC,Chen CH, Lu ML. Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication . J Psychopharmacol .2019

36. 2019 Chen LY,Chen CK,Chen CH,Chang HM,Huang MC,Xu K. Association of Craving and Depressive Symptoms in Ketamine-Dependent Patients Undergoing Withdrawal Treatment. . Am J Addict .2019

37. 2019 Goh KK,Liu YW,Kuo PH,Chung YE,Lu ML,Chen CH . Effect of probiotics on depressive symptoms: A meta-analysis of human studies . Psychiatry Res. .2019

38. 2019 Ya-Chin Lee,Yu-Lin Chao,Chiao-Erh Chang,Ming-Hsien Hsieh,Kuan-Ting Liu,Hsi-Chung Chen, Mong-Liang Lu, Wen-Yin Chen, Chun-Hsin Chen, Mong-Hsun Tsai, Tzu-Pin Lu, Ming-Chyi Huang, Po-Hsiu Kuo. Transcriptome Changes in Relation to Manic Episode . Front Psychiatry . .2019

39. 2018 Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials. . . Int J Psychiatry Clin Pract .2018

40. 2018 Chen VC,Chen CH,Chiu YH,Lin TY,Li FC,Lu ML. Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophrenia . Psychoneuroendocrinology .2018 ;(92):34-40

41. 2018 Cheng WJ,Chen CH,Chen CK,Huang MC,Pietrzak RH,Krystal JH, Xu K. Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia . Schizophr Res .2018 ;(199):313-318

42. 2017 Chu CS,Sun IW,Begum A,Liu SI,Chang CJ,Chiu WC, Chen CH, Tang HS, Yang CL, Lin YC, Chiu CC, Stewart R. The association between subjective memory complaint and objective cognitive function in older people with previous major depression. . PLOS ONE .2017 ;(12)

43. 2017 Huang MC,Lai YC,Lin SK,Chen CH. Increased Blood 8-hydroxy-2-deoxyguanosine Levels in Methamphetamine Users during Early Abstinence . The American Journal of Drug and Alcohol Abuse .2017 ;(44):395-402

44. 2017 Lu ML,Chen TT,Kuo PH,Hsu CC,Chen CH. Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study . Schizophrenia Research .2017 ;(193):126-133

45. 2017 Lu ML,Chen CH,Kuo PT,Lin CH,Wu TH. Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia . Schizophrenia Research .2017 ;(193):139-145

46. 2016 ,Huang MC, Chu HH. Smartphone-based support system (SoberDiary) coupled with a Bluetooth breathalyser for treatment-seeking alcohol-dependent patients . Addictive Behavior .2016 ;(65):174-178

47. 2016 Yang YH,Chiu CC,Teng HW,Chu CP,Chang CJ,Chiu WC, Chen CH, Lu ML, Liu SI, Huang SY, Liu HC, Sun IW.. Methionine synthase 2756AA polymorphism is associated with the risk of cognitive impairment in patients with late-life depression . Asia Pac Psychiatry . .2016

48. 2016 Lu ML,Wu YX,Chen CH,Kuo PT,Chen YH,Lin CH, Wu TH. Application of Plasma Levles of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia . PLOS ONE .2016 ;(11)

49. 2016 Chiu CC,Lu ML,Huang MC,Chen PY,Lin YK,Lin SK, Chen CH. Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study . PLOS ONE .2016

50. 2015 Cheng WJ,Huang MC,Cheng Y,Chen CH,Chen CJ. Consumption of alcoholic energy drinks is associated with work-related injury or disease among manual workers in Taiwan . Alcohol and Alcoholism .2015 ;(50):458-464

51. 2015 Chen PY,Lu ML,Huang MC,Kao CF,Kuo PH,Chiu CC, Lin SK and Chen CH. The Relationships of Obesity-Related Genetic Variants With Metabolic Profiles and Response to Metformin in Clozapine-Treated Patients With Schizophrenia . J Clin Psychopharmacol .2015 ;(35):574-578

52. 2015 Thurber S,Kishi Y,Trzepacz PT,Franco JG,Meagher DJ,Lee Y, Kim JL, Furlanetto LM, Negreiros D, Huang MC, Chen CH, Kean J, Leonard M. Confirmatory Factor Analysis of the Delirium Rating Scale Revised-98 (DRS-R98). . J Neuropsychiatry Clin Neurosci .2015 ;(27):122-127

53. 2014 Huang MC,Chen CH,Pan CH,Lin SK. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary reposrt of a randomized, double-blind, placebo-controlled trial . J Clin Psychopharm .2014 ;(34):149-152

54. 2014 Hunag MC,Chen CC,Pan CH,Chen CH. Comparison of Oxidative DNA Damage between Alcohol-dependent Patients with and without Delirium Tremens. . Alcohol Clin Exp Res .2014 ;(38):2523-2528

55. 2014 Huang MC,Kao CF,Chiu CC,Kuo PH,Chen PY,Lu ML, Chen CH. The genetic association of FTO variants with metabolic traits in patients with schizophrenia may be modified by antipsychotics . J Clin Psychopharmacology .2014 ;(34):162-165

56. 2013 Chen CH,Huang MC,Kao CF,Lin SK,Kuo PH,Chiu CC, Lu ML. Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia
and the Effect of Metformin Discontinuation on Body Weight:
A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study. . Journal of Clinical Psychiatry .2013 ;(74):424-430

57. 2013 Huang MC,Lin SK,Chen CH,Pan CH,Lee CH,Liu HC. Oxidative stress status in recently abstinent methamphetamine abusers . Psychiatry Clin Neurosci .2013 ;(67):92-100

58. 2013 Franco JG,Trzepacz PT,Meagher DJ,Kean J,Lee Y,Kim JL, Kishi Y, Furlanetto LM, Negreiros D, Huang MC, Chen CH, Leonard M, de Pablo J.. Three Core Domains of Delirium Validated Using Exploratory and Confirmatory Factor Analyses . Psychosomatics .2013

59. 2012 Chiu CC,Chen CH,Huang MC,Chen PY,Tsai CJ,Lu ML. The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder . J Clin Psychopharmacol .2012 ;(32):585-592

60. 2012 Trzepacz PT,Franco JG,Meagher DJ,Lee Y,Kim JL,Kishi Y, Furlanetto LM, Negreiros D, Huang MC, Chen CH, Kean J, Leonard M.. Phenotype of subsyndromal delirium using pooled multicultural Delirium Rating Scale--Revised-98 data. . J Psychosom Res .2012 ;(73):10-17

61. 2012 Chen CH,Walker J,Momenan R,Rawlings R,Heilig M,Hommer DW. Relationship between liver function and brain shrinkage in patients with alcohol dependence . Alcohol Clin Exp Res .2012 ;(36):625-632

62. 2011 Chen CH,Pan CH,Chen CC,Huang MC. Increased oxidative DNA damage in patients with alcohol dependence and its correlation with alcohol withdrawal severity. . Alcohol Clin Exp Res. .2011 ;(35):338-344

63. 2011 Kuo PH,Kao CF,Chen PY,Chen CH,Tsai YS,Lu ML, Huang MC. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients. . Journal of Clinical Psychopharmacology .2011 ;(31):705-11

64. 2011 Huang MC,Chen CH,Lin HC,Chen CC,Ho CC,Leu SJ. Differential Patterns of Serum Brain-Derived Neurotrophic Factor Levels in Alcoholic Patients with and without Delirium Tremens During Acute Withdrawal. . Alcoholism: Clin Exp Res .2011 ;(35):1-6

65. 2011 Chun-Hsin Chen,Mong-Liang Lu,Po-Hsiu Kuo,Po-Yu Chen,Chih-Chiang Chiu,Chung-Feng Kao. Gender differences in the effects of peroxisome proliferator-activated receptor γ2 . Progress in Neuro-Psychopharmacology & Biological .2011 ;(35):239-245

66. 2011 Chen CH,Lin TY,Chen TT,Chen VC,Lin NC,Shao WC, Lu ML. A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test . Prog Neuropsychopharmacol Biol Psychiatry .2011 ;(35):965-969

67. 2011 Chiu YH,Chen CH,Lu ML. Worsening psychosis after adding aripiprazole to clozapine. . Prog Neuropsychopharmacol Biol Psychiatry .2011 ;(35):291-292

68. 2011 Chen PY,Huang MC,Chiu CC,Liu HC,Lu ML,Chen CH. Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia . Prog Neuropsychopharmacol Biol Psychiatry .2011 ;(35):1927-1932

69. 2010 Chen CH,Shen WW,Lu ML. Resolution of tardive dyskinesia after the switch to aripiprazole . Acta Neuropsychiatrica .2010 ;(22):162-163

70. 2010 Chiu CC,Chen CH,Chen BY,Yu SH,Lu ML. The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine . Prog Neuropsychopharmacol Biol Psychiatry. .2010 ;(34):866-870

71. 2010 Huang MC,Ho CW,Chen CH,Liu SC,Chen CC,Leu SJ. Reduced Expression of Circadian Clock Genes in Male Alcoholic Patients. . Alcoholism: Clinical and Experimental Research .2010 ;(34):1899-1904

72. 2009 Huang MC,Lu ML,Tsai CJ,Chen PY,Chiu CC,Jian DL, Lin KM, Chen CH. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan . Acta Psychia Scand .2009 ;(120):274-280

73. 2009 Cheng WJ,Huang MC,Huang PS,Gau YF,Chen CH. Chinese Version of the Severity of Alcohol Dependence Questionnaire: Reliability and Factor Structure in Male Patients with Alcohol Dependence . Taiwan J Psychiatry .2009 ;(23):159-166

74. 2009 Lai YC,Huang MC,Chen CH,Tsai CJ,Pan CH,Chiu CC. Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders . Psychiatry Clin Neurosci. .2009 ;(63):440-448

75. 2009 Huang MC,Chen CH,Peng FC,Tang SH,Chen CC. Alterations in oxidative stress status during early alcohol withdrawal in alcoholic patients . J Formos Med Assoc. .2009 ;(108):560-569

76. 2009 Huang MC,Lee CH,Lai YC,Kao YF,Lin HY,Chen CH. Chinese version of the Delirium Rating Scale-Revised-98: reliability and validity . Comp Psychiatry .2009 ;(50):81-85

77. 2009 Huang MC,Chen CC,Peng FC,Tang SH,Chen CH. The Correlation between Early Alcohol Withdrawal Severity and Oxidative Stress in Patients with Alcohol Dependence . Prog Neuropsychol Biol Psychiatry .2009 ;(33):66-69

78. 2009 Huang MC,Yu CH,Chen CT,Chen CC,Shen WW,Chen CH. Prevalence and Identification of Alcohol Use Disorders among Severe Mental Illness Inpatients in Taiwan . Psychiat Clin Neurosci .2009 ;(63):94-100

79. 2009 Chen CH,Lu ML. Venlafexine-induced excessive yawning . Prog Neuropsychol Biol Psychiatry .2009 ;(33):156-157

80. 2008 Chen CH,Huang MC,Lu ML. Aripiprazole resolves symptomatic hyperprolactinemia and sexual dysfunction in a male schizophrenic patient . Prog Neuropsychol Biol Psychiatry .2008 ;(32):893-894

81. 2008 Chiu YH,Chen CH,Shen WW. Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder . Prog Neuropsychol Biol Psychiatry .2008 ;(32):581-582

82. 2008 Huang MC,Chen CH,Chen CH,Leu SC,Ho CJ,Shen WW, Leu SJ. Alterations of Serum Brain-Derived Neurotrophic Factor Levels in Early Alcohol Withdrawal . Alcohol Alcohol .2008 ;(43):241-245

83. 2008 Chang CJ,Chen CH,Lu ML. Cabergoline-induced psychotic exacerbation in schizophrenic patients . Gen Hosp Psychiatry .2008 ;(30):378-380

84. 2008 Chen CH,Chiu CC,Huang MC,Lu ML. Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine . Prog Neuropsychol Biol Psychiatry .2008 ;(32):925-931

85. 2008 Lu ML,Shen WW,Chen CH. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole . Prog Neuropsychol Biol Psychiatry .2008 ;(32):1978-1981

86. 2007 Huang MC,Lin HY,Chen CH. Dependence on zolpidem . Psychiat Clin Neurosci .2007 ;(61):207-208

87. 2007 Chen CH,Huang MC,Lu ML. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients . J Clin Psychopharmacol .2007 ;(27):516-517

88. 2007 Lai YC,Chiu CC,Chen CH,Huang MC. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone . J Clin Psychopharmacol .2007 ;(27):523-524

89. 2006 Chen CH,Huang MC,Shen WW. Readiness to change of problem drinkers in a general hospital Problem Drinkers in a General Hospital in Taiwan . Taiwan J Psychiatry .2006 ;(20):201-210

90. 2005 Chen CH,Chen WJ,Cheng ATA. A New Approach to the Validity of the Alcohol Use Disorders Identification Test: Stratum-specific Likelihood Ratios Analysis . Alcohol Clin Exp Res .2005 ;(29):602-608

91. 2005 Huang MC,Chen CH,YU JM,Chen CC. A Double-blind, Placebo-controlled Study of Naltrexone in the Treatment of Alcohol Dependence in Taiwan . Addict Biol .2005 ;(10):289-292

92. 2005 Huang MC,Chen CH,Yu CY,Yuh JF,Lai YC,Lin SK. The Reliability of the Chinese Version of the Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar) . Taiwan J Psychiatry .2005 ;(19):250-253

93. 2004 Chen CH,Chen WJ,Cheng ATA. Prevalence and Identification of Alcohol Use Disorders among Non-psychiatric Inpatients in One General Hospital . Gen Hosp Psychiatry 2004 26(3): 219-25 .2004 ;(26):219-225

94. 1999 Chen CH,Lee YJ,Hsu CY,Tsai CS,Chen CC. Narcolepsy with schizophrenic-like manifestations: a case report . Taiwanese J Psychiatry 1999;13(2):161-67 .1999 ;(13):161-167


1. 2020 Chen Chun-Hsin. Psychophysiological effects of Lactobacillus Plantarum PS128 in patients with major depressive disorder: a preliminary 8-week open trial . CINP 2020 .2020

2. 2020 Chen Chun-Hsin. Supplementation of folate and vitamin B12 in patients with schizophrenia and low serum folate level: a 24-week randomized, double-blind, placebo-controlled study . CINP .2020

研究計畫

計畫名稱
113 憂鬱症病人神經軸突完整性研究
補助單位
國家科學及技術委員會

計畫名稱
112 探討憂鬱症患者的腎素-血管收縮素系統(2/2)
補助單位
國家科學及技術委員會

計畫名稱
111 探討憂鬱症患者的腎素-血管收縮素系統(1/2)
補助單位
國家科學及技術委員會

計畫名稱
109 益生菌PS128對重鬱症患者之生理及憂鬱症狀影響:八周之隨機,雙盲,安慰劑控制試驗
補助單位
科技部

計畫名稱
108 益生菌PS128對重鬱症患者之生理及憂鬱症狀影響:八周之隨機,雙盲,安慰劑控制試驗
補助單位
科技部

計畫名稱
107 益生菌PS128對重鬱症患者之生理及憂鬱症狀影響:八周之前瞻性開放試驗
補助單位
科技部

計畫名稱
106 益生菌PS128對重鬱症患者合併高發炎指數之生理及憂鬱症狀影響:八周之前瞻性開放試驗
補助單位
科技部

計畫名稱
105 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係以及甲基葉酸與維生素B12的介入研究(3/3)
補助單位
科技部

計畫名稱
105 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係以及甲基葉酸與維生素B12的介入研究(3/3)
補助單位

計畫名稱
104 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係以及甲基葉酸與維生素B12的介入研究(2/3)
補助單位
科技部

計畫名稱
104 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係以及甲基葉酸與維生素B12的介入研究(2/3)
補助單位
科技部

計畫名稱
103 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係以及甲基葉酸與維生素B12的介入研究(1/3)
補助單位
科技部

計畫名稱
103 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係以及甲基葉酸與維生素B12的介入研究(1/3)
補助單位
科技部

計畫名稱
102 單碳循環路徑與精神分裂症患者之精神病理學和代謝異常的關係
補助單位
台北市立萬芳醫院委託財團法人私立臺北醫學大學辦理

計畫名稱
100 精神分裂症患者之基因啟動子甲基化相關研究及與內在表型的關係
補助單位
行政院國家科學委員會

計畫名稱
99 服用Clozapine之精神分裂症患者之代謝異常調查及Metformin對其體內代謝指標改變之研究
補助單位
行政院國家科學委員會

計畫名稱
98 服用Clozapine之精神分裂症患者之代謝異常調查及Metformin對其體內代謝指標改變之研究
補助單位
行政院國家科學委員會

計畫名稱
96 服用Clozapine之精神分裂症患者之代謝異常調查及Metformin對其體內代謝指標改變之研究
補助單位
行政院國家科學委員會

計畫名稱
95 動機式晤談法對危險性飲酒者之飲酒行為改變的成效評估
補助單位
行政院衛生署

計畫名稱
92 簡短介入對危險性飲酒者之成效評估
補助單位
行政院衛生署